about   CII home   shop   checkout



Search



Displaying items 1 to 20 of 30
August 25-26, 2020
Ubiquitin-Induced Targeted Protein Degradation
San Diego, CA
August 25-26, 2020
Kinase Inhibitor Chemistry
San Diego, CA
August 26-27, 2020
Small Molecules for Immunology and Oncology
San Diego, CA
August 28, 2020
RNA as a Small Molecule Target
San Diego, CA
August 28, 2020
Lead Optimization for Drug Metabolism & Safety
San Diego, CA
August 31 - September 1, 2020
Antibodies for Cancer Therapy
Boston, MA
September 2-3, 2020
Advancing Bispecific Antibodies and Combination Therapy to the Clinic
Boston, MA
September 16-17, 2020
Target Identification and Validation – Part 1
Boston, MA
September 16-17, 2020
PROTACs and Targeted Protein Degradation - Part 1
Boston, MA
September 16-17, 2020
CNS, Gene and Cel Therapy
Boston, MA
September 16-17, 2020
Disease Modeling
Boston, MA
September 16-17, 2020
Immunology and Oncology: Emerging Drug Targets and Therapeutics
Boston, MA
September 16-17, 2020
Targeting NASH
Boston, MA
September 17-18, 2020
Targeting Fibrosis
Boston, MA
September 17-18, 2020
PROTACs and Targeted Protein Degradation - Part 2
Boston, MA
September 17-18, 2020
Preclinical Strategies, Models & Tools in Oncology
Boston, MA
September 17-18, 2020
Target Identification and Validation – Part 2
Boston, MA
October 6, 2020
Immunology for Biotherapeutics
Alexandria, VA
October 6, 2020
Bispecific Antibodies for Cancer Immunotherapy
Boston, MA
October 7, 2020
Adoptive Cell Therapy
Boston, MA

CHI Partners

Genetic Engineering News 

BioProcess International